Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture. Positive aspects include strategic plans for IMSR plant deployment, targeting a significant market, and flexible reactor designs. However, concerns arise from increased cash burn, supply chain challenges, and regulatory hurdles. The Q&A reveals some uncertainty in management responses, particularly regarding timelines and regulatory pathways. While the commercial pipeline and strategic focus are promising, financial health and execution risks temper enthusiasm. Given these factors, a neutral sentiment rating is appropriate, suggesting limited stock price movement in the near term.
Total Cash and Cash Investments $289.9 million at quarter end, compared to $297.8 million at year-end 2025. This represents a decrease of $7.9 million, driven by cash burn due to a $600,000 payment for 2025 discretionary bonuses, a $1 million paydown of accounts payable for vendors offering extended credit terms, and $200,000 higher sequential payments for research and development costs.
Cash Burn $7.9 million for the quarter, an increase of $1.8 million compared to the prior quarter. The increase was due to one-time transaction costs associated with the 2025 merger, including discretionary bonuses and accounts payable paydown.
Research and Development Expenses Increased by $1 million sequentially, driven by fuel development and graphite testing programs.
General and Administrative Expenses Increased by $4.6 million sequentially, primarily due to headcount and stock-based compensation as the company builds out its public company team. The prior quarter included a $2.7 million credit from legal and accounting expenses capitalized during the merger.
IMSR Plant Differentiation: The IMSR plant is designed to be 1/6 the size of a conventional nuclear plant, with steam turbines operating at 50% greater efficiency than light water reactors. It uses standard nuclear fuel, avoiding the challenges of HALEU fuel supply.
Engineering and Regulatory Developments: Progress was made on Project TETRA (test reactor assembly) and Project TEFLA (fuel line assembly). The NRC approved the PIE Topical Report, establishing a methodology for IMSR safety analysis and licensing.
Commercial Pipeline Expansion: Executed an MOU with Riot Platforms to co-locate IMSR Plants with data centers for AI and high-performance computing. The pipeline now includes 10 IMSR Plant projects, representing 7.8 gigawatts of indicative power capacity.
Cash Management: Cash and cash investments stood at $289.9 million at quarter-end, with a cash burn of $7.9 million for the quarter. Increased expenses were attributed to discretionary bonuses, accounts payable, and R&D costs.
R&D and Operational Investments: Research and development expenses increased by $1 million sequentially, driven by fuel development and graphite testing programs. General and administrative expenses rose by $4.6 million due to headcount and stock-based compensation.
Fuel Strategy: The IMSR plant's use of standard nuclear fuel (less than 5% U-235) avoids the challenges of HALEU fuel supply, reducing costs and regulatory complexity.
HALEU Fuel Supply Challenges: The company has avoided using HALEU fuel, which is required by other Generation IV reactors, due to its considerable challenges, costs, and uncertainty in commercial-scale supply. This decision reduces regulated complexity and cost but highlights the broader industry's challenges with HALEU fuel supply.
Regulatory and Licensing Risks: The company is navigating complex regulatory processes with the Nuclear Regulatory Commission (NRC). While progress has been made, such as the approval of the PIE Safety Evaluation Report, the regulatory pathway remains critical for future licensing and deployment of IMSR plants.
Supply Chain Development: The company is actively building its supplier group for reactor components and fuel supply infrastructure. However, supply chain execution remains a critical area of focus to ensure timely and efficient project completion.
Cash Burn and Financial Management: The company experienced an increase in cash burn due to discretionary bonuses, paydown of accounts payable, and higher R&D costs. This trend is expected to continue as the company scales its operations, which could impact financial sustainability if not managed effectively.
Commercial Pipeline Execution: The company has a commercial pipeline of approximately 10 IMSR plant projects, but successful execution depends on overcoming challenges related to deployment readiness, supply chain, and regulatory approvals.
Electricity Demand Expectations: Electricity demand is expected to rise, driven by AI infrastructure, reshoring of manufacturing capacity, and broader electrification.
IMSR Plant Deployment: The company is focused on deploying IMSR plants, which are smaller, more efficient, and safer than conventional nuclear plants. The goal is to establish a fleet of IMSR plants operating in the 2030s.
Fuel Strategy: The IMSR plant uses standard nuclear fuel (less than 5% U-235), avoiding the challenges and costs associated with HALEU fuel supply.
Regulatory Milestones: The company achieved foundational regulatory milestones, including the NRC's approval of the PIE Topical Report, which establishes safety analysis methodology and licensing predictability for IMSR plants.
Commercial Pipeline: The commercial pipeline includes approximately 10 IMSR plant projects, representing 7.8 gigawatts of indicative power capacity. A new MOU with Riot Platforms aims to co-locate IMSR plants with data centers for AI and high-performance computing applications.
Cash Burn and Investment: Cash burn is expected to increase throughout 2026 due to scaling of organization, material testing, supplier selection, and project-related work.
The selected topic was not discussed during the call.
The earnings call presents a mixed picture. Positive aspects include strategic plans for IMSR plant deployment, targeting a significant market, and flexible reactor designs. However, concerns arise from increased cash burn, supply chain challenges, and regulatory hurdles. The Q&A reveals some uncertainty in management responses, particularly regarding timelines and regulatory pathways. While the commercial pipeline and strategic focus are promising, financial health and execution risks temper enthusiasm. Given these factors, a neutral sentiment rating is appropriate, suggesting limited stock price movement in the near term.
The earnings call reveals several challenges: increased financial losses, regulatory hurdles, supply chain dependencies, and competitive pressures. While the company targets a large market, these risks overshadow potential gains. The Q&A session did not alleviate concerns, with management avoiding specifics on project maturity. The lack of shareholder return discussion and increased expenses further contribute to a negative sentiment. Without strong positive catalysts, the stock is likely to experience a negative reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.